Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD

V. Osman-Hicks, P. Albert, P. Calverley (Liverpool, Merseyside, United Kingdom)

Source: Annual Congress 2008 - Organisation of care and management of COPD
Session: Organisation of care and management of COPD
Session type: Thematic Poster Session
Number: 3323
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Osman-Hicks, P. Albert, P. Calverley (Liverpool, Merseyside, United Kingdom). Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD. Eur Respir J 2008; 32: Suppl. 52, 3323

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019


Impact of influenza vaccination in patients with CAP
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004



The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain)
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005

Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018


Indication of pneumococcal vaccination in CF patients
Source: Eur Respir J 2001; 18: Suppl. 33, 539s
Year: 2001

Outcome of influenza vaccination in elderly with pneumonia
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008



Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough.
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021


Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002